Programmed Death 1 Expression as a Marker for Immune and Physiological Dysfunction in the Critically Ill Surgical Patient

Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia

(2012) Maciej Grzywnowicz et al.   PLoS One

Mechanisms of Indirect Acute Lung Injury

(2011) Sean F. Monaghan et al.   ANNALS OF SURGERY

Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis

(2010) P. Brahmamdam et al.   JOURNAL OF LEUKOCYTE BIOLOGY

T-CELL ACTIVATION DIFFERENTIALLY MEDIATES THE HOST RESPONSE TO SEPSIS

(2010) Kevin R. Kasten et al.   SHOCK

NEUTROPHIL PARALYSIS IN SEPSIS

(2010) José C. Alves-Filho et al.   SHOCK

Sympathetic Hyperactivity After Traumatic Brain Injury and the Role of Beta-Blocker Therapy

(2010) Daithi S. Heffernan et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Using serial severity scores to predict death in ICU patients: a validation study and review of the literature

(2009) Eric J Gartman et al.   Current Opinion in Critical Care

PD-1 signaling in primary T cells

(2009) James L. Riley   IMMUNOLOGICAL REVIEWS

Revisiting the validity of APACHE II in the trauma ICU: Improved risk stratification in critically injured adults

(2009) Lesly A. Dossett et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS

(2009) Ji-Young Rhee et al.   SHOCK

The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients

(2008) Nicholas S. Ward et al.   CLINICS IN CHEST MEDICINE